United StatesCertain safety net providers would pay capped drug prices upfront
Certain safety net providers would pay no more than the 340B price cap when buying covered outpatient drugs, without depending on repayment later.
What it does
Certain safety net providers would pay no more than the 340B price cap when they buy covered outpatient drugs. Drug makers could not charge more upfront and repay the difference later.
Argument forEligible providers could avoid paying above the price cap while they wait for a rebate on covered drugs.
Argument againstDrug makers might need to change payment systems and existing agreements that rely on later rebates for these providers.
More detail
The federal health secretary could not enter agreements with drug makers that require covered providers to pay above the 340B price cap at purchase. It applies to specified providers in the 340B drug discount program, including sole community hospitals. One listed group must receive money directly from a state or local government. Drug makers could not charge above the cap at purchase and repay the difference later. If enacted, the rule would cover drugs bought on or after enactment. Existing manufacturer agreements would be judged against it starting then.
Where do you stand?
Choose your position
Tell your reps
Take a position to see your representatives and ways to contact them.
Where it stands
- Introduced
- Passed House
- Passed Senate
- To President
- Became Law
Looking ahead
No hearings or votes scheduled.
History
- 2026
- Oct 29Introduced in HouseLatest
- Oct 29Referred to the House Committee on Energy and Commerce.Introduced
Healthcare